Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 5
1946 21
1947 23
1948 27
1949 31
1950 36
1951 47
1952 37
1953 27
1954 28
1955 23
1956 42
1957 31
1958 36
1959 31
1960 40
1961 39
1962 40
1963 78
1964 119
1965 154
1966 310
1967 377
1968 397
1969 354
1970 422
1971 355
1972 399
1973 493
1974 602
1975 674
1976 709
1977 882
1978 1687
1979 1948
1980 16814
1981 35161
1982 36320
1983 36927
1984 38478
1985 39390
1986 40507
1987 41908
1988 43265
1989 44985
1990 47310
1991 49091
1992 49605
1993 50153
1994 51635
1995 52371
1996 52672
1997 53238
1998 54742
1999 56022
2000 58282
2001 59765
2002 62932
2003 67561
2004 75254
2005 82182
2006 91249
2007 97868
2008 108176
2009 114483
2010 124052
2011 133614
2012 138668
2013 144211
2014 146269
2015 147434
2016 142089
2017 136823
2018 139150
2019 140009
2020 152745
2021 159676
2022 146219
2023 143979
2024 104537
2025 213
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,488,454 results

Results by year

Filters applied: . Clear all
Page 1
Defining the risk of SARS-CoV-2 variants on immune protection.
DeGrace MM, Ghedin E, Frieman MB, Krammer F, Grifoni A, Alisoltani A, Alter G, Amara RR, Baric RS, Barouch DH, Bloom JD, Bloyet LM, Bonenfant G, Boon ACM, Boritz EA, Bratt DL, Bricker TL, Brown L, Buchser WJ, Carreño JM, Cohen-Lavi L, Darling TL, Davis-Gardner ME, Dearlove BL, Di H, Dittmann M, Doria-Rose NA, Douek DC, Drosten C, Edara VV, Ellebedy A, Fabrizio TP, Ferrari G, Fischer WM, Florence WC, Fouchier RAM, Franks J, García-Sastre A, Godzik A, Gonzalez-Reiche AS, Gordon A, Haagmans BL, Halfmann PJ, Ho DD, Holbrook MR, Huang Y, James SL, Jaroszewski L, Jeevan T, Johnson RM, Jones TC, Joshi A, Kawaoka Y, Kercher L, Koopmans MPG, Korber B, Koren E, Koup RA, LeGresley EB, Lemieux JE, Liebeskind MJ, Liu Z, Livingston B, Logue JP, Luo Y, McDermott AB, McElrath MJ, Meliopoulos VA, Menachery VD, Montefiori DC, Mühlemann B, Munster VJ, Munt JE, Nair MS, Netzl A, Niewiadomska AM, O'Dell S, Pekosz A, Perlman S, Pontelli MC, Rockx B, Rolland M, Rothlauf PW, Sacharen S, Scheuermann RH, Schmidt SD, Schotsaert M, Schultz-Cherry S, Seder RA, Sedova M, Sette A, Shabman RS, Shen X, Shi PY, Shukla M, Simon V, Stumpf S, Sullivan NJ, Thackray LB, Theiler J, Thomas PG, Trifkovic S, Türeli S, Turn… See abstract for full author list ➔ DeGrace MM, et al. Nature. 2022 May;605(7911):640-652. doi: 10.1038/s41586-022-04690-5. Epub 2022 Mar 31. Nature. 2022. PMID: 35361968 Free PMC article. Review.
The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immunity induced after infection or vaccination. To address the public health threat caused by the increasing SARS-CoV-2 genomic diversit …
The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immu …
Will ARPA-H work?
Thorp HH. Thorp HH. Science. 2022 Apr 15;376(6590):223. doi: 10.1126/science.abq4814. Epub 2022 Apr 14. Science. 2022. PMID: 35420930
A new federal agency-approved last month by the United States Congress-is already off to a rocky start. The Advanced Research Projects Agency for Health (ARPA-H), proposed by President Biden in 2021, aims to tackle the most intractable biomedical probl …
A new federal agency-approved last month by the United States Congress-is already off to a rocky start. The Advanced Resear …
Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?
Whitehead SS. Whitehead SS. Expert Rev Vaccines. 2016;15(4):509-17. doi: 10.1586/14760584.2016.1115727. Epub 2015 Dec 2. Expert Rev Vaccines. 2016. PMID: 26559731 Free PMC article. Review.
Although the multi-dose vaccine demonstrated protection against severe dengue, its overall efficacy was limited by DENV serotype, serostatus at vaccination, region and age. The National Institute of Allergy and Infectious Diseases has developed …
Although the multi-dose vaccine demonstrated protection against severe dengue, its overall efficacy was limited by DENV serotype, serostatus …
Controlling research trials.
Drazen JM. Drazen JM. N Engl J Med. 2003 Apr 3;348(14):1377-80. doi: 10.1056/NEJMe030031. N Engl J Med. 2003. PMID: 12672866 No abstract available.
NIH research: think globally.
Fauci AS, Collins FS. Fauci AS, et al. Science. 2015 Apr 10;348(6231):159. doi: 10.1126/science.aab2733. Science. 2015. PMID: 25859018 Free PMC article. No abstract available.
The NIH-NIAID Schistosomiasis Resource Center at the Biomedical Research Institute: Molecular Redux.
Cody JJ, Ittiprasert W, Miller AN, Henein L, Mentink-Kane MM, Hsieh MH. Cody JJ, et al. PLoS Negl Trop Dis. 2016 Oct 20;10(10):e0005022. doi: 10.1371/journal.pntd.0005022. eCollection 2016 Oct. PLoS Negl Trop Dis. 2016. PMID: 27764112 Free PMC article. Review.
Continued and vigorous research efforts must therefore be directed at this disease, particularly since only a single World Health Organization (WHO)-approved drug is available for treatment. The National Institutes of Health (NIH)-Nati …
Continued and vigorous research efforts must therefore be directed at this disease, particularly since only a single World Health …
The NIAID/RNCP Biodosimetry Program: An Overview.
Satyamitra MM, Cassatt DR, Molinar-Inglis O, Rios CI, Taliaferro LP, Winters TA, DiCarlo AL. Satyamitra MM, et al. Cytogenet Genome Res. 2023;163(3-4):89-102. doi: 10.1159/000534213. Epub 2023 Sep 22. Cytogenet Genome Res. 2023. PMID: 37742625 Free PMC article. Review.
Established in 2004, the Radiation and Nuclear Countermeasures Program (RNCP), within the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health has the central mission to advance …
Established in 2004, the Radiation and Nuclear Countermeasures Program (RNCP), within the National Institute of Allergy …
Development of a Universal Influenza Vaccine.
Estrada LD, Schultz-Cherry S. Estrada LD, et al. J Immunol. 2019 Jan 15;202(2):392-398. doi: 10.4049/jimmunol.1801054. J Immunol. 2019. PMID: 30617121 Free PMC article. Review.
The severity of the 2017-18 influenza season, combined with the low efficacy for some vaccine components, highlights the need to improve our current seasonal influenza vaccine. Thus, the National Institute of Allergy and Infectious Diseases rece …
The severity of the 2017-18 influenza season, combined with the low efficacy for some vaccine components, highlights the need to improve our …
Radiation-induced multi-organ injury.
Molinar-Inglis O, DiCarlo AL, Lapinskas PJ, Rios CI, Satyamitra MM, Silverman TA, Winters TA, Cassatt DR. Molinar-Inglis O, et al. Int J Radiat Biol. 2024;100(3):486-504. doi: 10.1080/09553002.2023.2295298. Epub 2024 Jan 2. Int J Radiat Biol. 2024. PMID: 38166195
METHODS: The Radiation and Nuclear Countermeasures Program within the National Institute of Allergy and Infectious Diseases partnered with the Biomedical Advanced Research and Development Authority to convene a virtual two-day meeting tit …
METHODS: The Radiation and Nuclear Countermeasures Program within the National Institute of Allergy and Infectious …
3,488,454 results
You have reached the last available page of results. Please see the User Guide for more information.